The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes
出版年份 2022 全文链接
标题
The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes
作者
关键词
-
出版物
GYNECOLOGIC ONCOLOGY
Volume 165, Issue 3, Pages 560-567
出版商
Elsevier BV
发表日期
2022-03-31
DOI
10.1016/j.ygyno.2021.11.019
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma
- (2020) Matthew K. Stein et al. JOURNAL OF SURGICAL ONCOLOGY
- The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance
- (2020) Lauren P. Cobb et al. GYNECOLOGIC ONCOLOGY
- MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
- (2020) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities
- (2020) Dane Cheasley et al. JOURNAL OF PATHOLOGY
- Next-Generation Sequencing in 305 Consecutive Patients: Clinical Outcomes and Management Changes
- (2019) William Davis et al. Journal of Oncology Practice
- Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer
- (2018) Shahrooz Rabizadeh et al. Oncotarget
- Clinical validation of the Tempus xO assay
- (2018) Nike Beaubier et al. Oncotarget
- Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)
- (2017) A. Spreafico et al. GYNECOLOGIC ONCOLOGY
- Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
- (2017) Diana Mandelker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors
- (2017) Rajyalakshmi Luthra et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial
- (2017) Chih-Jian Lih et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory
- (2017) Meenakshi Mehrotra et al. PLoS One
- Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors
- (2016) Rashmi S. Goswami et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
- (2016) Jacek P. Grabowski et al. GYNECOLOGIC ONCOLOGY
- Multigene Clinical Mutational Profiling of Breast Carcinoma Using Next-Generation Sequencing
- (2015) Sinchita Roy-Chowdhuri et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum
- (2015) David M Gershenson et al. BRITISH JOURNAL OF CANCER
- Factors affecting the success of next-generation sequencing in cytology specimens
- (2015) Sinchita Roy-Chowdhuri et al. CANCER CYTOPATHOLOGY
- Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor
- (2015) David M. Gershenson et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
- (2015) Sally M. Hunter et al. Oncotarget
- Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours
- (2014) R R Singh et al. BRITISH JOURNAL OF CANCER
- Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
- (2014) C. Emmanuel et al. CLINICAL CANCER RESEARCH
- Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes
- (2013) Rajesh R. Singh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- KRAS(but notBRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
- (2013) Yvonne T Tsang et al. JOURNAL OF PATHOLOGY
- BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
- (2012) Rachel N. Grisham et al. CANCER
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- Low-grade serous carcinomas of the ovary contain very few point mutations
- (2011) Siân Jones et al. JOURNAL OF PATHOLOGY
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- (2010) Kwong-Kwok Wong et al. AMERICAN JOURNAL OF PATHOLOGY
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now